Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.66 - $2.31 $3,321 - $4,622
2,001 Added 1.57%
129,403 $287,000
Q2 2023

Aug 14, 2023

BUY
$1.61 - $1.96 $81,404 - $99,101
50,562 Added 65.8%
127,402 $236,000
Q3 2022

Nov 14, 2022

BUY
$0.94 - $5.99 $23,518 - $149,869
25,020 Added 48.28%
76,840 $380,000
Q2 2022

Aug 15, 2022

BUY
$3.2 - $5.69 $165,824 - $294,855
51,820 New
51,820 $243,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.